Adicet Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	119	82	383	559	275	54	242
Market Cap Growth	-	-78.70%	-31.46%	102.95%	407.15%	-77.55%	-
Enterprise Value	-20	-57	146	302	198	-12	134
PE Ratio	-0.57	-0.57	-5.49	-9.01	-7.51	-1.93	-26.01
PS Ratio	-	-	15.33	57.44	15.38	54.57	29.56
PB Ratio	0.70	0.48	1.31	1.84	2.51	-0.90	2.32
P/FCF Ratio	-0.83	-0.83	-6.22	-8.72	-6.47	-1.88	-12.69
P/OCF Ratio	-0.87	-0.87	-8.56	-10.95	-6.63	-1.95	-13.30
EV/Sales Ratio	-	-	5.86	31.05	11.05	-12.44	16.35
EV/EBITDA Ratio	0.43	0.43	-2.26	-5.22	-5.29	0.46	-15.43
EV/EBIT Ratio	0.40	0.40	-2.10	-4.88	-5.03	0.44	-13.52
EV/FCF Ratio	0.58	0.58	-2.38	-4.71	-4.65	0.43	-7.02
Debt / Equity Ratio	0.12	0.12	0.07	0.07	0.20	-	-
Debt / EBITDA Ratio	-0.16	-0.16	-0.32	-0.36	-0.58	-	-
Debt / FCF Ratio	-0.21	-0.21	-0.34	-0.33	-0.51	-	-
Quick Ratio	8.28	8.28	13.07	17.03	4.41	4.49	18.91
Current Ratio	8.41	8.41	13.25	17.31	4.46	4.32	19.16
Asset Turnover	0	0	0.07	0.03	0.16	0.01	0.07
Interest Coverage	-5705.32	-5705.32	-871.37	-351.98	-293.72	-	-
Return on Equity (ROE)	-65.60%	-65.60%	-23.00%	-25.20%	-39.30%	-35.50%	-8.10%
Return on Assets (ROA)	-55.80%	-55.80%	-20.60%	-21.60%	-32.10%	-23.20%	-7.50%
Return on Capital (ROIC)	-79.56%	-79.56%	-23.15%	-18.96%	-29.81%	52.00%	-14.36%
Earnings Yield	-119.73%	-174.87%	-18.22%	-11.09%	-13.32%	-51.82%	-3.85%
FCF Yield	-82.40%	-120.35%	-16.07%	-11.47%	-15.45%	-53.10%	-7.88%
Buyback Yield / Dilution	-4.78%	-4.78%	-32.72%	-322.84%	-242.22%	-9.86%	-239.91%
Total Shareholder Return	-4.78%	-4.78%	-32.72%	-322.84%	-242.22%	-9.86%	-239.91%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).